NCT02329405View on ClinicalTrials.gov

The Effects of PXR Activation on Hepatic Fat Content

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

Rifampicin

DRUG

Placebo

Trial Locations (1)

90029 OYS

Oulu University Hospital, Oulu

All Listed Sponsors
collaborator

Oulu University Hospital

OTHER

lead

University of Oulu

OTHER

NCT02329405 - The Effects of PXR Activation on Hepatic Fat Content | Biotech Hunter | Biotech Hunter